A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer

Anticancer Research

Volumn 33, Issue 8, 2013, Pages 3291-3294

  Shibutani, Masatsune ^a   Maeda, Kiyoshi ^a   Nagahara, Hisashi ^a   Noda, Eiji ^a   Ohtani, Hiroshi ^a   Nishiguchi, Yukio ^b   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Division of Digestive Surgery of Osaka Municipal General Medical Center   (Japan)

Author keywords

Colorectal cancer; Neutrophil to lymphocyte ratio; Systemic inflammatory response

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COLORECTAL CANCER; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL TO LYMPHOCYTE RATIO; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

COLORECTAL CANCER; NEUTROPHIL-TO-LYMPHOCYTE RATIO; SYSTEMIC INFLAMMATORY RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PREOPERATIVE CARE; PROGNOSIS; ROC CURVE;

EID: 84883307604     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Sobin LH, Gospodarowicz MK and Wittekind C: UICC. TNM Classification of Malignant Tumors. Seventh edition. New York: Wiley-Liss, 2009.
2. GoVL and Zamcheck N: The role of tumor markers in the management of colorectal cancer. Cancer 50: 2618-2623, 1982.
3. Tang R, Yeh CY, Wang JY, Changchien CR, Chen JS and Hsieh LL: Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection. Ann Surg Oncol 16: 2516-2523, 2009.
4. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
5. Balkwill F and Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 357: 539-545, 2001.
6. Nozoe T, Mori E, Takahashi I and Ezaki T: Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today 38: 597-602, 2008.
7. Garcea G, Ladwa N, Neal CP, Metcalfe MS, Dennison AR and Berry DP: Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg 35: 868-872, 2011.
8. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P and Lim E: Neutrophil/lymphocyte ratio and its association with survival after completeresection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137: 425-428, 2009.
9. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y and Fukushima M: The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73: 215-220, 2007.
10. Hung HY, Chen JS, Yeh CY, Changchien CR, Tang R, Hsieh PS, Tasi WS, You JF, You YT, Fan CW, Wang JY and Chiang JM: Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who did not receive adjuvant chemotherapy. Int J Colorectal Dis 26: 1059-1065, 2011.
11. Mallapa S, Sinha A, Gupta S and Chadwick SJ: Preoperative neutrophil lymphocyte ratio>5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis 15: 323-328, 2013.
12. Walsh SR, Cook EJ, Goulder F, Justin TA and Keeling NJ: Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncology 91: 181-184, 2005.
13. Chinng SF, Hung HY, Tang R, Changchien CR, Chen JS, You YT, Chiang JM and Lin JR: Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis 27: 1347-1357, 2012.
14. Kaneko M, Nozawa H, Sasaki K, Hongo K, Hiyoshi M, Tada N, Murono K, Nirei T, Kawai K, Sunami E, Tsuno NH and Kitayama J: Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy. Oncology 82: 261-268, 2012.
15. Neal CP, Mann CD, Sutton CD, Garcea G, Ong SL, Steward WP, Dennison AR and Berry DP: Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastasis. Eur J Cancer 45: 56-64, 2009.
16. Terzic J, Grivennikov S, Karin E and Karin M: Inflammation and colon cancer. Gastroenterology 138: 2101-2114, 2010.
17. Lin EY and Pollard JW: Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90: 2053-2058, 2010.
18. An X, Ding PR, Li YH, Wang FH, Shi YX, Wang ZQ, He YJ, Xu RH and Jiang WQ: Elevated neutrophil to lymphocyte ration predicts survival in advanced pancreatic cancer. Biomarkers 15: 516-522, 2010.
19. Japanese Society for Cancer of the Colon, Rectum: General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Seventh edition. Tokyo: Kanehara, 2006.